Airway Clearance Devices for Cystic Fibrosis - Market Insights, Competitive Landscape, and Market Forecast - 2032

Airway Clearance Devices for Cystic Fibrosis Market by Device Type (High-Frequency Chest Wall Oscillation Device, Positive Expiratory Pressure Devices, Mechanical Percussion (MP) Devices, and Others), End-User (Hospitals & Clinics, Home Healthcare, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2032 owing to the growing prevalence of cystic fibrosis and respiratory disorders and rising incidence of genetic diseases

The airway clearance devices for cystic fibrosis market is estimated to grow at a CAGR of 5.03% during the forecast period from 2025 to 2032. The demand for airway clearance devices for cystic fibrosis is primarily driven by the growing prevalence of cystic fibrosis, increasing genetic disease cases, growing R&D activities, and research collaboration among key players are some of the key factors responsible for contributing to the positive growth of airway clearance devices for the cystic fibrosis market during the forecast period from 2025 to 2032.

Airway Clearance Devices for Cystic Fibrosis Market Dynamics:

The airway clearance devices are created based on physiological principles that work by creating resistance and vibration that help to loosen and clear mucous from airway walls to enhance sputum clearance. According to a report published by the UK Parliament in January 2023, stated that approximately 10,800 people were living with cystic fibrosis in 2023 in the United Kingdom. According to Vertex Pharmaceuticals Incorporated in May 2024, it was estimated that 92,000 people were diagnosed with cystic fibrosis across the globe. Airway clearance devices help to manage cystic fibrosis by clearing the airway walls, thus, the rising prevalence of cystic fibrosis is expected to drive the market growth.

Cystic fibrosis is a genetic condition caused by gene abnormality that causes the production of abnormally thick and sticky liquid called mucous. According to NHS England in February 2024, approximately 3.5 million people were affected by genetic diseases in 2021 in the United Kingdom and this number comprises 1 in 17 people being affected by a rare disease. Therefore, the rising occurrence of rare genetic diseases contributes to increased cases of cystic fibrosis which is contributing to the growth of the market.

Key players in the market are concentrating their efforts on developing and commercializing airway clearance devices for hospital and home healthcare applications. For instance, in December 2022, ABM Respiratory Care announced the U.S. Food and Drug Administration (FDA) 510(k) clearance of the BiWaze(R) Clear System. This airway clearance system helps patients clear their airways as well as prevent or treat cystic fibrosis by using oscillating lung expansion (OLE) therapy. Therefore, the increasing research and development activities by key players are driving the growth of airway clearance devices for the cystic fibrosis market.

However, the complications associated with airway clearance devices, and product recalls, among others are some of the key constraints that may hinder the growth of airway clearance devices for the cystic fibrosis market.

Airway Clearance Devices for Cystic Fibrosis Market Segment Analysis:

Airway Clearance Devices for Cystic Fibrosis Market by Device Type (High-Frequency Chest Wall Oscillation Device, Positive Expiratory Pressure Devices, Mechanical Percussion (MP) Devices, and Others), End-User (Hospitals & Clinics, Home Healthcare, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the device type segment of airway clearance devices for the cystic fibrosis market, the high-frequency chest wall oscillation device category is estimated to hold the largest revenue share in the airway clearance devices for the cystic fibrosis market in 2024. High-frequency chest wall oscillation devices use mechanical oscillations or vibrations on the chest wall to aid in the clearance of accumulated mucus from the airways, facilitating its loosening and mobilization. This device is also used for the treatment of chronic lung diseases which require clearance of sputum and mucous from airway walls.

Key players in the market are developing advanced devices for the management of cystic fibrosis and other disease that require devices for airway clearances. For instance, in November 2022, Electromed, Inc. announced that it received U.S Food and Drug Administration 510(k) clearance for the SmartVest(R) Clearway(R) Airway Clearance System, which is designed for High-Frequency Chest Wall Oscillation therapy. This device works by delivering alternating pulses of air into a vest, causing rapid compression and release of the chest wall. This process generates airflow oscillations within the airways, which serve to loosen, thin, and propel mucus towards the larger airways for easier expectoration.

Therefore, the growing use of high-frequency chest wall oscillation devices in cystic fibrosis is expected to contribute to the growth of the segment, thereby driving the growth of the airway clearance devices for the cystic fibrosis market during the forecast period.

North America is expected to dominate the overall Airway Clearance Devices for Cystic Fibrosis Market:

North America is expected to hold dominate market share in the airway clearance devices for cystic fibrosis market in 2024. This is due to the growing prevalence of cystic fibrosis in the region. The rising number of people suffering from cystic fibrosis requiring airway clearance devices to manage disease conditions in the region is a key factor driving the growth of the North America airway clearance devices for cystic fibrosis market.

Air clearance devices mechanically conducts chest physical therapy through high-frequency vibrations. The vest vibrates the chest to help loosen and thin thick, sticky mucus commonly found in cystic fibrosis. According to data published by Centers for Disease Control and Prevention (CDC) in May 2024, approximately 35,000 peoples were suffering with cystic fibrosis in 2024 in the United States. Therefore, the rising cases of cystic fibrosis is expected to drive the market growth in North America.

Airway Clearance Devices for Cystic Fibrosis Market Key Players:

Some of the key market players operating in the airway clearance devices for cystic fibrosis market include Baxter, Koninklijke Philips N.V., Electromed, Inc., ICU Medical, Inc., Trudell Medical International, CEGLA Medizintechnik GmbH, PARI GmbH, Monaghan, VORTRAN Medical Technology 1 Inc., Tactile Medical, Mercury Medical, Med Systems, Inc., Vyaire Medical, Inc., Synchrony Medical, Dymedso, SunMed LLCWestmed, Inc., RespInnovation, Inogen, Inc., Thayer Medical, Medline Industries, LP, and others.

Recent Developmental Activities in the Airway Clearance Devices for Cystic Fibrosis Market:

• In September 2023, Inogen, Inc. completed the acquisition of Physio-Assist SAS. Through this acquisition, Inogen acquired Simeox from Physio-Assist which is a technology-enabled airway clearance and mucus management device for treatment of cystic fibrosis.
• In September 2021, Tactile Medical completed acquisition of AffloVest respiratory therapy business from International Biophysics Corporation. This acquisition strengthened the position of Tactile Medical in cystic fibrosis treatment market and increased its product portfolio and global presence.

Key Takeaways from the Airway Clearance Devices for Cystic Fibrosis Market Report Study

• Market size analysis for current Airway Clearance Devices For Cystic Fibrosis Market size (2024), and market forecast for 8 years (2025 to 2032)
• Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
• Key companies dominating the global Airway Clearance Devices for Cystic Fibrosis market.
• Various opportunities available for the other competitors in the Airway Clearance Devices for Cystic Fibrosis Market space.
• What are the top-performing segments in 2024? How these segments will perform in 2032?
• Which are the top-performing regions and countries in the current Airway Clearance Devices for Cystic Fibrosis market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for Airway Clearance Devices for Cystic Fibrosis market growth in the coming future?

Target Audience who can be benefited from this Airway Clearance Devices for Cystic Fibrosis Market Report Study

• Airway Clearance Devices For Cystic Fibrosis product providers
• Research organizations and consulting companies
• Airway Clearance Devices For Cystic Fibrosis related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and Traders dealing in Airway Clearance Devices For Cystic Fibrosis
• Various end-users who want to know more about the Airway Clearance Devices for Cystic Fibrosis Market and the latest technological developments in the Airway Clearance Devices for Cystic Fibrosis Market.

Frequently Asked Questions for the Airway Clearance Devices for Cystic Fibrosis Market:

1. What are Airway Clearance Devices for Cystic Fibrosis?

• Airway clearance devices for cystic fibrosis are specialized devices that mechanically aid in clearing thick, sticky mucus from the airways, thereby enhancing lung function and improving airways wall clearance.

2. What is the market for Airway Clearance Devices for Cystic Fibrosis?

• The airway clearance devices for cystic fibrosis market is estimated to grow at a CAGR of 5.03% during the forecast period from 2025 to 2032.

3. What are the drivers for the global Airway Clearance Devices for Cystic Fibrosis market?

• The airway clearance devices for cystic fibrosis market is slated to witness prosperity owing to factors such as the growing prevalence of cystic fibrosis, increasing genetic disease cases, growing R&D activities, research collaborations among key players are some of the key factors responsible for contributing to the positive growth of the airway clearance devices for cystic fibrosis market during the forecast period from 2025 to 2032.

4. Who are the key players operating in the global Airway Clearance Devices for Cystic Fibrosis market?

• Some of the key market players operating in the airway clearance devices for cystic fibrosis market include Baxter, Koninklijke Philips N.V., Electromed, Inc., ICU Medical, Inc., Trudell Medical International, CEGLA Medizintechnik GmbH, PARI GmbH, Monaghan, VORTRAN Medical Technology 1 Inc., Tactile Medical, Mercury Medical, Med Systems, Inc., Vyaire Medical, Inc., Synchrony Medical, Dymedso, SunMed LLCWestmed, Inc., RespInnovation, Inogen, Inc., Thayer Medical, Medline Industries, LP, and others.

5. Which region has the highest share in the global Airway Clearance Devices For Cystic Fibrosis market?

• North America is expected to hold dominate market share in the airway clearance devices for cystic fibrosis market in 2024. This is due to the growing prevalence of cystic fibrosis in the region. Thus the rising number of people suffering from cystic fibrosis requiring airway clearance devices to manage disease conditions in the region is a key factor driving the growth of the North America airway clearance devices for cystic fibrosis market.